梅特勒-托利多 MTD 深 沪
已收盘 02-06 16:00:00 美东时间
1373.57
-9.280
-0.67%
华盛通- 最 高1392.98
- 今 开1384.03
- 成交量 22.97万股
- 最 低 1325.05
- 昨 收 1382.85
- 总市值 280.60亿
- 52周最高 1525.17
- 市盈率 静 32.67
- 换手率 1.12%
- 52周最低 946.69
- 委 比 0.00%
- 总股本 2042.84万
- 历史最高 1714.75
- 量 比 1.61
- 振 幅 4.91%
- 历史最低 126.10
- 每 手 1
- 风险率 122.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | 梅特勒-托利多 2025财年Q4营收11.30亿美元，同比增长8.1%；归母净利润2.86亿美元，同比增长13.3%
华盛资讯2月6日讯，梅特勒-托利多公布2025财年Q4业绩，公司Q4营收11.30亿美元，同比增长8.1%，归母净利润2.86亿美元，同比增长13.3%。
02-06 13:52
Mettler-Toledo Intl Sees Q1 Adj EPS $8.60-$8.75 vs $8.95 Est; Sees Sales $910.256M vs $936.960M Est
Mettler-Toledo Intl (NYSE:MTD) is looking for Q1 Adj EPS of $8.60-$8.75 vs $8.95 analyst estimate. sees sales of $910.256 million vs $936.960 million analyst estimate.
02-06 05:37
Mettler-Toledo Intl: Q4 Earnings Insights
The earnings results for Mettler-Toledo Intl (NYSE:MTD) for Q4 were made public...
02-06 05:32
Mettler-Toledo Intl Q4 Adj. EPS $13.36 Beats $12.82 Estimate, Sales $1.130B Beat $1.104B Estimate
Mettler-Toledo Intl (NYSE:MTD) reported quarterly earnings of $13.36 per share which beat the analyst consensus estimate of $12.82 by 4.22 percent. This is a 7.66 percent increase over earnings of $12.41 per share from
02-06 05:31
DIARY-U.S. earnings week ahead
DIARY-U.S. earnings week ahead Jan 30 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 02-Feb-2026 BMO APTV Aptiv PLC Q4 2025 Aptiv PLC Earnings Release 02-Feb-2026 AMC DVA DaVita Inc Q4 2025 DaVita Inc Earnings R
01-31 01:00
Federal appeals court rejects NIH research funding cuts
A U.S. appeals court has ruled against the Trump administration’s moves to implement drastic cuts to federal grant funding provided by the National Institutes of Health (NIH) to cover overhead costs i...
01-06 20:16
AI潮涌，常州竞逐全国“智能体+场景应用”示范城市
寒冬时节，梅特勒-托利多中国常州太湖路工厂内，仍忙得热火朝天。员工在生产线旁轻敲键盘，一套定制化生产方案便能“一键生成”。产线一端，AI正检测着产品质量。通过...
01-03 16:12
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
Wells Fargo Maintains Equal-Weight on Mettler-Toledo Intl, Raises Price Target to $1450
Wells Fargo analyst Brandon Couillard maintains Mettler-Toledo Intl (NYSE:MTD) with a Equal-Weight and raises the price target from $1400 to $1450.
2025-12-16 02:28
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
